Business

Neurizon Submits Clinical Hold Complete Response to FDA

Neurizon Submits Clinical Hold Complete Response to FDA

Neurizon Therapeutics LimitedJuly 24, 20254
Neurizon Submits Clinical Hold Complete Response to FDA

About this update from Neurizon Therapeutics Limited

Neurizon Therapeutics Limited has released a press release. View Attachment

View stock analysis, news, and events for Neurizon Therapeutics Limited

More from Neurizon Therapeutics Limited

All Neurizon Therapeutics Limited news →